Patrick Lindsay: Pharma's Lifecycle Partner, Pharmaceutical Executive

 

Patrick Lindsay: Pharma's Lifecycle Partner, Pharmaceutical Executive

The strategic uncertainty confronting big Pharma today has put a premium on generating new ideas from outside sources – it’s the fresh wind that lifts the sails. CROs and other biopharma vendors with a business mission to guide the industry through an era of rapid change are under intense pressure to keep up, with service offerings that bind strategy to execution and are global and cross-functional in scope. In the following interview, part of our “CEO Snapshot” series, Pharm Exec sits down with Patrick Lindsay, President of UBC [United BioSource], a scientific, medical affairs, and risk management advisory firm geared to meeting industry needs at every stage of product life-cycle. Jamaican-born Lindsay, 53, and a co-founder of UBC offers an update on the company’s recent merger with drug distribution giant Express Scripts, which puts him and UBC at the center of what is now the nation’s largest supply chain on medicines, filling nearly a third of all prescriptions written in the US. Pharmaceutical Executive, December 2013